Select language:  
1800 620 420
Close menu

Cancer Australia PdCCRS recipients

Meet the new 2022 Grant Recipients and learn more about their research projects

Dr Kate Vandyke

Is it possible to predict myeloma risk by looking at factors produced by ageing bone marrow cells?

Dr Camille Guillery

Can we prevent relapse in children with leukaemia by using natural cells found in umbilical cord blood?

Dr Rachel Thijssen

Understanding more about why people with chronic lymphocytic leukaemia can become resistant to treatment.

Learn more about PdCCRS Cancer Australia Grants

Blood-cancer-research

Previous recipients

Dr Hannah Wardill

Testing new ways to minimise or prevent the debilitating and potentially deadly graft vs host disease (GvHD) in children who undergo a stem cell transplant.

Dr Kyohei Nakamura

Working towards a new approach to improve the body’s immune response against B-cell lymphoma.

Dr Nakamura

Dr Laurence Cheung

Studying the interaction between bone and leukaemia cells to improve treatment outcomes in childhood leukaemia

Laurence Cheung

Dr Melissa Cantley

Developing new tests to identify which individuals with smouldering myeloma are at risk of developing myeloma

Melissa Cantley

Dr Kate Vandyke

Increasing the efficiency while decreasing toxicity of myeloma therapies

Kate Vandyke

Dr Laura Bray

Developing new models for drug testing to understand the biology and mechanisms of drug resistance in AML

Dr Laura Bray

Dr Michelle Henderson

Developing a new drug a as a novel therapeutic strategy for aggressive leukaemia in children

Michelle Henderson

Dr Jenny Wang

Developing a new targeted therapy with minimal side effects and toxicity to improve the outcome of childhood AML

Jenny Wang

Dr Gabriela Brumatti

Using novel combination therapy to increase the changes of cure for childhood AML

Gabriela Brumatti